These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26384308)

  • 1. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
    Lee M; Beggs SM; Gildea D; Bupp S; Lichtenberg J; Trivedi NS; ; Hu Y; Bodine DM; Crawford NP
    Oncotarget; 2015 Oct; 6(31):31557-68. PubMed ID: 26384308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer.
    De Faveri LE; Hurst CD; Platt FM; Taylor CF; Roulson JA; Sanchez-Carbayo M; Knowles MA; Chapman EJ
    Br J Cancer; 2013 Apr; 108(6):1368-77. PubMed ID: 23549060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
    Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
    Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.
    Bihani T; Ezell SA; Ladd B; Grosskurth SE; Mazzola AM; Pietras M; Reimer C; Zinda M; Fawell S; D'Cruz CM
    Oncotarget; 2015 Feb; 6(4):2407-20. PubMed ID: 25537515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis.
    Kurita M; Kuwajima T; Nishimura I; Yoshikawa K
    J Neurosci; 2006 Nov; 26(46):12003-13. PubMed ID: 17108174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
    Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
    Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.
    Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC
    Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necdin: a multi functional protein with potential tumor suppressor role?
    Chapman EJ; Knowles MA
    Mol Carcinog; 2009 Nov; 48(11):975-81. PubMed ID: 19626646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Role of Huntingtin in Breast Cancer Metastasis.
    Thion MS; McGuire JR; Sousa CM; Fuhrmann L; Fitamant J; Leboucher S; Vacher S; du Montcel ST; Bièche I; Bernet A; Mehlen P; Vincent-Salomon A; Humbert S
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26293574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.